Literature DB >> 4404646

Medical approach to ophthalmopathy of Graves' disease.

H K Ivy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4404646

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  9 in total

Review 1.  Pharmacological treatments for thyroid eye disease.

Authors:  Sara P Modjtahedi; Bobeck S Modjtahedi; Ahmad M Mansury; Dinesh Selva; Raymond S Douglas; Robert A Goldberg; Igal Leibovitch
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 2.  Thyroid eye disease.

Authors:  D H Char
Journal:  Br J Ophthalmol       Date:  1996-10       Impact factor: 4.638

Review 3.  Immunosuppressant therapy of thyroid eye disease.

Authors:  G Kahaly; J Beyer
Journal:  Klin Wochenschr       Date:  1988-11-01

4.  Eyelid malpositions in Graves' ophthalmopathy.

Authors:  R R Waller
Journal:  Trans Am Ophthalmol Soc       Date:  1982

5.  Treatment of thyroid associated ophthalmopathy with periocular injections of triamcinolone.

Authors:  R Ebner; M H Devoto; D Weil; M Bordaberry; C Mir; H Martinez; L Bonelli; H Niepomniszcze
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

Review 6.  Steroids and the eye--indications and complications.

Authors:  W J Dinning
Journal:  Postgrad Med J       Date:  1976-10       Impact factor: 2.401

7.  Dysthyroid ophthalmopathy: an update.

Authors:  L A Young
Journal:  J Natl Med Assoc       Date:  1979-09       Impact factor: 1.798

8.  Evaluation of endocrine ophthalmopathy with saccadic eye movements.

Authors:  L Mauri; O Meienberg; E Roth; M P König
Journal:  J Neurol       Date:  1984       Impact factor: 4.849

9.  Palpebral asymmetry and hyperthyroidism. Two cases in connection with Graves' disease.

Authors:  P A Uldry; F Regli; B R Scazziga; C Naegeli
Journal:  J Neurol       Date:  1986-04       Impact factor: 4.849

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.